| scholarly article | Q13442814 |
| P50 | author | Marc Caron | Q64858849 |
| P2093 | author name string | William C Wetsel | |
| Tanya L Daigle | |||
| P2860 | cites work | Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 |
| Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. | Q44376607 | ||
| Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. | Q44840053 | ||
| Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture | Q45712917 | ||
| Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications | Q46731448 | ||
| Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine | Q46815350 | ||
| Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice | Q47994629 | ||
| Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia | Q48124096 | ||
| Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. | Q48176645 | ||
| Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade. | Q48428637 | ||
| Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. | Q48452719 | ||
| Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization | Q48918978 | ||
| Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. | Q51423988 | ||
| Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol | Q56504097 | ||
| Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter | Q24310836 | ||
| Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- mice | Q24647599 | ||
| Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway | Q28215554 | ||
| Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 | Q28270721 | ||
| Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons | Q28272251 | ||
| Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons | Q28363375 | ||
| Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice | Q28469322 | ||
| Enhanced morphine analgesia in mice lacking beta-arrestin 2 | Q28504554 | ||
| Mice with reduced NMDA receptor expression display behaviors related to schizophrenia | Q28510751 | ||
| beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation | Q28512807 | ||
| Altered striatal function in a mutant mouse lacking D1A dopamine receptors | Q28585357 | ||
| Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice | Q28586296 | ||
| MAPK cascade signalling and synaptic plasticity | Q29619955 | ||
| Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia | Q30988635 | ||
| Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. | Q31813503 | ||
| Role of the ERK pathway in psychostimulant-induced locomotor sensitization. | Q33235276 | ||
| Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum | Q33723743 | ||
| Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 | ||
| Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference | Q34479672 | ||
| The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders | Q35586641 | ||
| Distribution of cannabinoid receptors in the central and peripheral nervous system. | Q36441196 | ||
| Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. | Q36514515 | ||
| ERK2: a logical AND gate critical for drug-induced plasticity? | Q36644968 | ||
| Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. | Q36999038 | ||
| The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain | Q39565180 | ||
| Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia | Q42486484 | ||
| Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice | Q42500923 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids | Q43517979 | ||
| Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. | Q43734938 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. | Q44334367 | ||
| delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| striatum | Q1319792 | ||
| P1104 | number of pages | 12 | |
| P304 | page(s) | 1378-1389 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling | |
| P478 | volume | 34 |
| Q36916041 | Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum. |
| Q36190481 | Elimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to muscarinic receptor activation |
| Q37671995 | Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects. |
| Q34068943 | Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission |
| Q36358395 | The Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3β Phosphorylation in Cerebellar Granular Neurons of Rat |
Search more.